Kymera Therapeutics

Vice President, Pricing & Market Access

Watertown, MA · Exec

Sponsorship not specifiedDetected 40 days ago

Business DevelopmentResearchLeadershipCollaboration

About the role

Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics.
For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.

Responsibilities

Lead global and U.S. pricing strategies across the portfolio, including launch pricing, lifecycle pricing, contracting, and access optimization.
Develop evidence-based pricing recommendations informed by market dynamics, unmet need, competitive landscapes, and payer insights.
Lead engagement strategies with U.S. payers, PBMs, integrated delivery networks, and government stakeholders.
Shape endpoint, outcomes, and real-world evidence strategies that support differentiation and value demonstration.
Lead access readiness and launch planning for late-stage programs.

Requirements

The ideal candidate will bring deep immunology expertise, preferably including atopic dermatitis and asthma, along with a proven track record of market access leadership across U.S. and global markets.

Skills

and experience you'll bring:
<li data-leveltex

Benefits

The Head of Pricing & Market Access will lead global and U.S. pricing, reimbursement, access, and value strategies across Kymera's pipeline and future commercial products.
Market Access & Reimbursement
Develop market access and reimbursement strategies aligned with Kymera's commercialization roadmap, including planned launches in atopic dermatitis and asthma.
Execute payer and reimbursement strategies to support successful launches and sustained access.
Partner with Clinical Development, Medical Affairs, and HEOR to ensure evidence-generation plans meet payer, HTA, and reimbursement requirements.
Develop pricing, access, reimbursement, and uptake assumptions for forecasting.
Serve as the company's expert on payer dynamics, healthcare policy, pricing trends, and reimbursement environments.

Company info

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
How we work:
PIONEER: We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines.
COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives.
Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions.
Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years.
BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
How you'll make an impact:
Reporting to the Chief Commercial Officer, this executive will play a critical role in maximizing patient access and commercial value by shaping payer, provider, government, and health-system strategies from late-stage development through launch and lifecycle management.
As a key member of the Commercial Leadership Team, this leader will partner closely with Marketing, Clinical Development, Medical Affairs, Regulatory, HEOR, Market Research, Finance, Business Development, and Corporate Strategy to ensure access considerations are embedded throughout development and commercialization planning.

Apply directly at Kymera Therapeutics →Create a free account for alerts like this View Kymera Therapeutics immigration profile

This listing is sourced directly from Kymera Therapeutics's careers page and normalized into a canonical job model.